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Abstract

ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE
CAFFEINE METABOLITE, PARAXANTHINE?

Kendra Jean Hartsuyker

Caffeine has diverse effects on neurons including, potentially, protection against
Parkinson’s-related neurodegeneration. Caffeine may protect neurons from damage by
limiting mitochondrial membrane permeability through a calcium-dependent mechanism.
This study was a first step investigating calcium’s role in caffeine neuroprotection in vivo
using zebrafish larvae. Elavl3:GCaMP6s zebrafish, which express a genetically encoded
fluorescent calcium indicator protein in most CNS neurons, received caffeine (0, 50, 125,
250 µM, bath applied) in an ascending dose series during fluorescence calcium imaging
of a central catecholaminergic nucleus (a proposed zebrafish homolog of the locus
coeruleus, a structure affected in Parkinson’s disease). Parallel experiments tested effects
of an ascending dose series of paraxanthine (0, 40, 100, 200 µM), a neuroactive caffeine
metabolite, to assess whether paraxanthine mediates caffeine effects. Five outcomes were
measured: spontaneous calcium oscillations, visually-evoked calcium responses,
spontaneous swimming activity, visually-evoked swimming, and heart rate (visual
responses were evoked by a sudden dimming of ambient illumination). Caffeine and
paraxanthine had no effect on the power of low frequency (<2Hz) calcium oscillations,
visually-evoked calcium responses, or heart rate, even at the highest doses. High doses of
ii
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caffeine and paraxanthine moderately but significantly suppressed swimming speed
during visually-evoked behavioral responses. Results suggest that the dose range used
was too low to produce expected effects of caffeine. Alternatively, caffeine may affect
stressed neurons differently from healthy neurons, a possibility we will examine in
similar experiments using MPTP challenge.
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Introduction
Parkinson’s disease (PD) is characterized as a neurodegenerative disorder
affecting mostly the elderly population. The neurodegeneration targets dopamine (DA)
producing neurons in the pars compacta of the substantia nigra (SN). The decrease in
dopaminergic neurons and subsequent DA loss has been hypothesized as a leading cause
to the debilitating degradation of voluntary motor control commonly seen in PD patients.
In PD, the root cause of DA cell death is still unknown (Lang & Lozano, 1998). One
theory examining mutations in mitochondrial DNA (mtDNA) proposes the propagation
of dopaminergic cell death may be due in part to a mitochondrial complex I deficiency in
PD patients. The mitochondrial complexes are proteins composing the electron transport
chain involved in energy production. Impairment of mitochondrial complex I may lead to
a significant increase in a toxic metabolite of DA, called 3, 4-dihydroxyphenylacetaldehyde (DOPAL), because of a decrease in nicotinamide adenine
dinucleotide (NAD), a cofactor for the enzyme responsible for metabolizing DOPAL.
(Burke et al., 2004; Lang & Lozano, 1998; Panneton, Kumar, Gan, Burke, & Galvin,
2010; Schapira et al., 1990). With this deficit, DOPAL accumulates in higher
concentrations than the average population. DOPAL reacts with H2O2 to produce free
radicals (Li, Lin, Minteer, & Burke, 2001). The concentrations of free radicals are
proposed to occur in high enough concentrations to induce the permeability transition
pore (PTP) of the mitochondria to change to its full conductance state (Burke et al., 2004;
Kluck, Bossy-Wetzel, Green & Newmeyer, 1997; Li et al., 2001; Scarlett & Murphy,
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1997). The PTP is a structure spanning the inner membrane and outer membrane
of the mitochondria allowing flow of calcium ions between the matrix and the cytoplasm.
Changing the PTP into its full conductance state disrupts the electrochemical gradient
causing swelling of the matrix releasing cytochrome c, a small protein, into the matrix
resulting in apoptotic cell death (Kristal, Matsuda, & Byung, 1996; Li et al., 2001).
Paraxanthine, the primary metabolite of caffeine, has neuroprotective effects on
DA cells in models of PD (Guerreiro, Toulorge, Hirsch, Marein, Sokoloff, & Michel,
2008; Xu, Xu, Chen, Schwarzchild, 2010). It is established that the neuroprotective effect
of paraxanthine is dependent on activation of ryanodine receptors (Guerreiro et al., 2008).
Ryanodine receptors are calcium (Ca2+) release channels located on the outer face of the
endoplasmic reticulum (ER) (Fill & Copello, 2002; Verkhratsky, 2005). Mitochondria are
physiologically close enough to the ER to create Ca2+ “hotspots”. These microdomains of
Ca2+ inhibit the mitochondria PTP from opening in its high conductance state, thus
preventing apoptotic cell death (Burke et al., 2004; Li et al., 2001; Mannella, Buttle,
Rath, & Marko, 1998; Rizzuto et al., 2003; Rizzuto, DeStefani, Raffello, & Mammucari,
2012; Szalai, Krishnamurth, & Hajnóczky, 1999; Szalai, Csordas, Hantash, Thomas, &
Hajnóczky, 2000; Verkhratsky, 2005).
Zebrafish are a widely used model organism in drug discovery. Functional
domains within proteins are highly conserved allowing the zebrafish to have a high
degree of drug response and physiological similarity to humans. The proposed
experiments will take advantage of the ability to measure neuronal calcium dynamics in
intact zebrafish larvae using optical methods to investigate how caffeine and
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paraxanthine affects intracellular calcium. By establishing the concentrations of both
compounds that are effective in activating the release of Ca2+ from the ER, these
experiments will provide critical information for subsequent studies designed to test
whether Ca2+ release from the ER protects against PD-related neuronal degeneration.
Paraxanthine is an active metabolite of caffeine and has not been tested in the zebrafish
before, so a secondary goal of these experiments is to determine to what extent caffeine’s
effects on neuronal calcium levels depends on the actions of paraxanthine.

3

ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE
CAFFEINE METABOLITE, PARAXANTHINE?
Literature Review
Parkinson’s Disease
Parkinson's’ disease (PD) has been classified as a neurodegenerative movement
disorder commonly diagnosed in the elderly population. PD affects approximately 2% of
the population over the age of 65 and 4-5% of the population over the age of 85, although
these are likely under estimates as under-diagnosis is fairly common (Lang & Lozano;
1998; Eriksen, Dawson, Dickson, & Petrucelli, 2003). Classic PD symptoms have been
characterized as bradykinesia, akinesia, rigidity, resting tremors, depression, sleep
deficits, and an impaired gait. (Lang & Lozano; 1998). The major symptoms of PD have
been linked to a loss of dopaminergic neurons in the Substantia Nigra (SN) and a loss of
dopamine (DA) in the Striatum (Burke et al., 2004; Hornykiewicz, 1993; Fearnley &
Lees, 1991; Panneton et al., 2010). The nigrostriatal DA neurons are responsible for
control over voluntary movements (Grillner & Mercuri, 2002).
Current treatments for PD, including the dopamine precursor drug, L-DOPA, and
deep brain stimulation, are focused on increasing DA availability in the synapse or
reducing tremors (Benabid, Chabardes, Mitrofanis, & Pollak, 2009; Cesura & Pletscher,
1992; Cools, Barker, Sahakain, & Robbins, 2003; Stefani et al., 2007). These treatments
relieve symptoms but do not prevent the continued death of dopaminergic neurons.
Therefore, genetic and cellular mechanisms of PD neurodegeneration are under active
investigation to identify degenerative processes that may be disrupted to rescue stressed
neurons and prevent further cell loss (Luo, Hoffer, Hoffer, & Oi, 2015; McNeill et al.,
2013; Winklhofer & Haas, 2011). Some of this research has revealed intracellular
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calcium regulation to be a critical process in dopaminergic cell loss and one that could
potentially be manipulated therapeutically (Cali, Ottolini & Brini, 2014; Hurley &
Dexter, 2012; Mattson, 2012; Orrenius, Nicotera, & Zhivotovsky, 2003; Rizzuto et al.,
2003).
Genetic mutations affecting mitochondria in Parkinson’s Disease. Many
studies have tried to find genes linked to PD predisposition (Klein & Westenberger,
2012; Polymeropoulos et al., 1997). However, these studies are examining nuclear genes
and have failed to find correlations, only found small effect sizes, or only accounted for a
small percent of PD cases. (Klein & Westenberger, 2012; Polymeropoulos et al., 1997).
Examining mitochondrial (mtDNA) may provide insight behind the pathology of PD.
mtDNA base pair deletions or insertions have already been identified in the pathology of
neurodegenerative diseases such a PD and Alzheimer’s disease (Wallace, 1999).
Inheritance of mitochondria during cell proliferation varies due to random chance.
Understanding the cellular inheritance pattern within an organism is important for
understand the role of mtDNA in disease because it explains the phenotypic variance that
occurs within cell populations.
Phenotypic expression of symptoms originating from mtDNA mutations are
highly variable (Wallace, 1999). If two individuals, even from the same family, have the
same mutation in their mtDNA, their phenotypic expression of the mutation may be
drastically different. Each cell holds a combination of hundreds mutant and wild type
mitochondria and within each mitochondria anywhere between 1,000 and 10,000 copies
of mtDNA are contained (Wallace, 1992; Winklhofer & Haass, 2011). Figure 1 shows the
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mitochondria in a cell undergoing mitosis. The mutant and wild type mitochondria are
randomly divided between the daughter cells. After multiple cellular divisions, genetic
variability among the ratio of mutant mitochondria and wild type mitochondria within the
cell may develop, and the mutant phenotype may be expressed in cells harboring a
greater ratio of the mutant mitochondria. The complex genetic and phenotypic variability
among cells with mtDNA mutations within individuals may be a contributing reason the
link of mutations in mtDNA and PD has been hard to establish.
Another impairment of normal mitochondrial function associated with PD
involves a mutation in mitochondrial complex I, which is the first protein in the electron
transport chain, leading to a deficit within PD patients. A deficiency in complex I
downregulates the production of nicotinamide adenine dinucleotide (NAD), which is a
cofactor needed for the enzyme aldehyde dehydrogenase (ALDH) to break down DOPAL
into 3,4-dihydroxyphenylacetic acid (DOPAC) (Burke et al., 2004). A study showed that
inhibiting ALDH increases DOPAL concentrations 12-fold when compared to controls
(Lamensdorf et al., 2000).
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Figure 1. Illustrates how uneven distribution of mutated mtDNA within cells undergoing
mitosis can lead to a variety of different phenotypes
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Mitochondrial function, dopamine metabolism, and risks for cell death
To understand the impact of a deficiency in complex I of the mitochondria, we
must examine the metabolic pathway of DA. Tyrosine is metabolized by tyrosine
hydroxylase into L-DOPA. DA is then synthesized from L-DOPA by DOPA
decarboxylase in the SN (Burke et al., 2004). Figure 2 shows DA is then metabolized
into 3, 4-dihydroxyphenylacetaldehyde (DOPAL) by monoamine oxidase (MAO)
(Cesura & Pletscher, 1992). It is important to note hydrogen peroxide (H2O2) is also
formed in the same reaction during the metabolism of DA into DOPAL (Burke et al.,
2004).
In humans, there are two distinct isoforms of MAO: MAO-A, located on the
cytosolic face of the mitochondria in the neurons, and MAO-B, located in the
surrounding astrocytes (Burke et al., 2004). MAO-A is the only MAO isoform
responsible for DA metabolism in striatal DA neurons (Fornai et al., 2000).
Although naturally forming, DOPAL is an unstable molecule, this instability can
make DOPAL toxic under certain cellular conditions, such as in the presence of H2O2
(Burke et al., 2004; Panneton et al., 2010). Normally DOPAL is rapidly cleaved by
aldehyde dehydrogenase (ALDH) into a less volatile molecule, DOPAC (Cesura &
Pletscher, 1992; Fornai et al., 2000; Panneton et al., 2010).
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Figure 4. Shows the location of the metabolic pathway of dopamine. The boxes
represent compounds and the circles represent enzymes. MAO-A, located on the
cytosolic face of the mitochondrion, metabolizes dopamine into DOPAL. The temporal
location of DOPAL and H2
Figure 5. a. The structure of the mitochondrion illustrating the low pH of the
intramembrane space and the high pH of the matrix. b. Represents the mitochondrial
permeability transition pore. The low conductance state shows a low flow of calcium
ions exiting the matrix to the cytoplasm. The high conductance state illustrates a high
flow of calcium ions exiting the matrix, along with the release of the protein
CypDFigure 6. Shows the location of the metabolic pathway of dopamine. The boxes
represent compounds and the circles represent enzymes. MAO-A, located on the
cytosolic face of the mitochondrion, metabolizes dopamine into DOPAL. The temporal
location of DOPAL and H2
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Evidence of DOPAL’s Toxicity
The most common PD medication, L-DOPA, is a metabolic precursor to DA. By
increasing the precursor compound, L-DOPA treatment increases DOPAL concentrations
downstream in the dopaminergic pathway. PD patients already experience higher than
average DOPAL levels due to a deficiency in mitochondrial complex I. Here we examine
how L-DOPA treatment, already causing an increase in DOPAL, may be interacting with
a mitochondrial complex I deficiency, a separate mechanism increasing DOPAL, to
further propagate dopaminergic cell death.
Evidence shows DOPAL, the primary metabolite of DA, can be toxic under
certain circumstances to the cells it is formed in, particularly for dopaminergic cells
within the SN (Panneton et al., 2010). The pars compacta of the SN, which is the group
of neurons controlling reward and movement, was particularly more affected by DOPAL,
due to the high concentrations of dopaminergic neurons, than the pars reticulata of the
SN, which has a relatively high concentration of GABAergic neurons (Panneton et al.,
2010). This is suggestive DOPAL is selectively toxic to DA neurons. An analysis of
postmortem human brain tissue from healthy donors showed an average DOPAL
concentration of 2.3 µM within the SN (Kristal, Conway, Brown, Jain, Ulluci, Li, &
Burke, 2001). This concentration was not found to be toxic to the cells. However, an in
vivo study showed that a slightly higher DOPAL concentration, 6 µM, is toxic to neurons
(Kristal et al., 2001). Injections of DOPAL into rat brains resulted in the loss of DA
neurons with concentrations of DOPAL as low as 100 ng (Burke et al., 2004). However,
injections at concentrations of 500 ng of DA showed no effects on DA neurons (W.
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Burke et al., 2004). Although DA is closely related to DOPAL, DA itself is not toxic
unless present in large concentrations, approximately 1M (Burke, Li, Williams, & Zham,
2003; Burke et al., 2004; Filloux & Townsend, 1993; Kristal et al., 2001).
L-DOPA, the most common PD medication, significantly increases DOPAL
concentrations. Injections of 10 µM of DA through dialysis probes into rat brains
increased DOPAL by 2,790% ±62 when compared with baselines (Fornai et al., 2000).
Similarly, injections of 50 mg/kg of L-DOPA through dialysis probes into rat brains
increased DOPAL levels by 1,861% ±70when compared to controls (Fornai et al., 2000).
In both experiments, DOPAC, the metabolite of DOPAL, did not experience a significant
increase. This is indicative of a “build up” of DOPAL within the brain. L-DOPA
treatments may lead to concentrations of DOPAL reaching toxic levels within cells.
In PD patients, the aforementioned mitochondrial complex I deficiency combine
with L-DOPA treatment may cause a significant increase in the cellular concentration of
the toxic compound DOPAL, furthering the propagation of DA cell death. The
mechanism of DOPAL mediated toxicity has been attributed to the production of free
radicals in the presence of H2O2 (Burke et al., 2004; Li et al., 2001). As mentioned above,
H2O2 is produced in the same reaction DOPAL is metabolized from DA (Burke et al.,
2004). The authors note the mechanism the free radicals are formed is unknown and a
recent literary search shows it is still unknown (Li et al. 2001). Free radicals are able to
induce the mitochondrial PTP into its full conductance state causing mitochondrial
swelling and the release of apoptotic proteins (Kristal et al., 1996; Li et al., 2001). This
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points to a therapeutic target by preventing free radicals from inducing the mitochondrial
PTP into its full conductance state.
The mitochondria’s major role within the cell is regulation of energy metabolism
and regulation of apoptotic pathways. Figure 3a shows the structure of mitochondria. It is
important to understand mitochondria structure for energy production and regulation of
apoptosis. Figure 2a shows mitochondria have two membranes, the outer membrane that
segregates the mitochondria from the intracellular environment (cytoplasm) and the inner
membrane that segregates the center of the mitochondria (matrix) from the
intermembrane space. These properties allow the generation of proton gradient across
membranes within mitochondria, and the dissipation of those proton gradient to drive the
production of adenosine triphosphate (ATP).
The mitochondrial PTP plays a critical role in normal mitochondrial function by
regulating the conductance of calcium between the matrix and the cytoplasm
(Azarashvili, Stricker, & Reiser, 2010; Ichas & Mazat, 1998; Patergnani et al., 2011;
Rizzuto et al., 2012; Szalai et al., 2000). Changes in the PTP activity can also contribute
to apoptosis (Azarashvili et al., 2010; Ichas & Mazat, 1998; Klucket al., 1997; Szalai,
Krishnamurthy, & Hajnoczky 1999).
Figure 3b shows the mitochondrial PTP is comprised of three proteins spanning
the outer membrane of the mitochondria to the matrix (Arrazola, Silva-Alvarez, &
Inestrosa, 2015; Azarashvili et al., 2010). One protein, the voltage dependent anion
channel (VDAC) is located on the outer membrane. A second component, adenine
nucleotide translocase (ANT) spans the inner membrane. The third component,

12

ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE
CAFFEINE METABOLITE, PARAXANTHINE?
cyclophilin D (CypD) is located on the matrix side of the inner membrane and is released
during PTP mediated cell death (Arrazola et al., 2015; Azarashvili et al., 2010).
The mitochondrial PTP operates in two distinct pathways, one controls Ca2+
signaling and the other controls the effector phase of apoptosis (Ichas & Mazat, 1998).
The PTP controls these pathways by openning in two different conductance states (Ichas
& Mazat, 1998). Figure 3b shows the conformation changes the VDAC, ANT, and CypD
proteins undergo to alter the conductance states and change the flow of Ca2+ ions
(Arrazola et al., 2015). The low conductance state is a regular part of maintaining cellular
Ca2+ homeostasis and normal cell functioning (Ichas & Mazat, 1998).
The high conductance state stabilizes the channel in a permanent open
conformation resulting in apoptosis (Ichas & Mazat, 1998). This causes an irreversible
dissipation of the membrane potential resulting in the loss of mitochondrial structure
through swelling of the mitochondrial matrix (Ichas & Mazat, 1998). The swelling forces
the outer mitochondrial membrane to burst resulting in the release of the apoptotic
proteins into the cytoplasm (Burke et al., 2004; Ichas & Mazat, 1998; Kothakota et al.,
1997; Kluck et al., 1997; Orrenius et al., 2003; Scarlett & Murphy, 1997; Youle &
Strasser, 2008).
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Figure 7. a. The structure of the mitochondrion illustrating the low pH of the
intramembrane space and the high pH of the matrix. b. Represents the mitochondrial
permeability transition pore. The low conductance state shows a low flow of calcium ions
exiting the matrix to the cytoplasm. The high conductance state illustrates a high flow of
calcium ions exiting the matrix, along with the release of the protein CypD
Figure 8. Quantification of spontaneous calcium fluorescence. A. Raw confocal video stack
consisting of 6,000 frames. B. Projection of average pixel values across the stack. Arrow
heads show individual neuron cell bodies the tart nucleus that can be resolved. C.
Threholded image showing isolation of the target nucleus as a density (particle) of blue
pixels. A smaller particle in the upper right of the image is not included because of a size
cut off. D. Isolated region of interest for subsequently measuring each from in the stack. E.
an example plot, from the same trials as panels A-D, showing calcium fluorescence
dynamics cross 20 minutesFigure 9. a. The structure of the mitochondrion illustrating the
low pH of the intramembrane space and the high pH of the matrix. b. Represents the
mitochondrial permeability transition pore. The low conductance state shows a low flow of
calcium ions exiting the matrix to the cytoplasm. The high conductance state illustrates a
high flow of calcium ions exiting the matrix, along with the release of the protein CypD
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Interaction of DOPAL with the Mitochondrial PTP. During the metabolic
breakdown of DA into DOPAL by MAO-A, H2O2 is formed as well. DOPAL interacts
with H2O2 forming free radicals (Burke et al., 2004). MAO-A is active on the cytosolic
face of the mitochondrial membrane less than 50 nm away from the mitochondrial PTP
(Burke et al., 2004). Concentrations of DOPAL as low as 125 nM create enough free
radicals to induce the high conductance state of the mitochondrial PTP, resulting in
apoptosis (Burke et al., 2004). The temporal location of free radicals formation relative to
the PTP allows for the free radicals to easily interact with the pore. This points to a
potential therapeutic target for PD namely, preventing the mitochondrial PTP from
entering its high conductance state by forcing the PTP to stabilize into its low
conductance state.
Paraxanthine as a Neuroprotectant
Approximately 80% of caffeine gets metabolized into paraxanthine in the liver
(Benowitz, Jacob, Mayan, & Denaro, 1995). It is important to note caffeine does not get
metabolized during its first pass through the liver (Arnaud, 1993). Caffeine is both
hydrophilic and lipophilic (Bonati, Latini, Galletti, Young, Tognoni, & Garattini, 1982).
Caffeine and paraxanthine share many pharmacological properties and actions, including
lipophilic properties (Denaro, Brown, Wilson, Jacob, & Benowitz, 1990). These
properties allow caffeine and paraxanthine to freely pass through all biological
membranes and the blood-brain barrier through simple diffusion and saturable carriermediated transport (Arnaud, 2011; McCall, Millington, & Wurtman, 1982; Verkhratsky,

15

ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE
CAFFEINE METABOLITE, PARAXANTHINE?
2002). Approximately 80% of caffeine passes into the brain during its first circulatory
pass (Oldendorf, 1971).
Studies have shown that the consumption of caffeine is negatively correlated with
risk for PD (Ascherio et al., 2001; Kalda, Yu, Oztas, & Chen, 2006; Xu et al., 2010). This
link has been supported by experimental studies, showing caffeine and its metabolites
have neuroprotective effects against PD-related toxicity such as that caused by exposure
to the selective DA neuron toxin, MPTP (Xu et al., 2002; Xu et al., 2010).
The neurotoxin MPTP is the metabolic precursor to the biologically active
molecule MPP+. MPTP is the gold standard for modeling PD as it induces similar
pathologies similar to those seen in PD in humans. Once MPP+ reaches DA neurons, it
interferes with mitochondrial complex I of the electron transport chain inducing
permanent Parkinsonian symptoms (Smeyne & Jackson-Lewis, 2005).
Originally, the neuroprotective effects of caffeine and paraxanthine were thought
to result from inhibition of adenosine receptors (Ascherio et al., 2001; Checkoway et al.,
2002; Chen et al., 2001; Kalda et al., 2006). However, research suggests the
neuroprotective effects are directly related to the opening of ryanodine receptors, Ca2+
release channels, and the subsequent rise in intracellular Ca2+ concentration (Guerreiro et
al., 2008). Ryanodine receptors are Ca2+ release channels located on the ER (Fill &
Copello, 2002; Verkhratsky, 2006).
Guerreiro et al. (2008) modeled PD through MPP+ exposure in differentiated
midbrain DA cells in a culture. Examining the dose-dependent neuroprotective effects of
caffeine and paraxanthine, they showed equal concentrations of paraxanthine had a
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significantly larger neuroprotective effect than caffeine. This is suggestive that the
neuroprotective effect of caffeine is, in part or in full, due to its metabolite paraxanthine.
The neuroprotective effect is caused by ryanodine receptor activation, rather than
adenosine receptor blockade. Activation of ryanodine receptors, using the agonist
dantrolene, exhibited similar neuroprotective effects when compared to paraxanthine.
Whereas blockade of ryanodine receptors, using a ryanodine receptor antagonist,
prevented the neuroprotective effects. Paraxanthine mediated activation of ryanodine
receptor results in a moderate elevation of intracellular cytosolic free calcium (Cacyt2+)
levels. A large increase in Cacyt2+ did not have a neuroprotective effect, suggesting the
Cacyt2+ concentration needs to be elevated just above normal levels to have a
neuroprotective effect.
Paraxanthine is most neuroprotective being treated for 10 days continuously after
MPP+ exposure at concentrations between 800 - 1000 µM treated in differentiated brain
cells. The researchers identified neuroprotection by quantifying cells expressing tyrosine
hydroxylase, the enzyme responsible for synthsizing L-DOPA. The paraxanthine
treatment group showed 194% more TH cells in the culture over the control group.
Critically, the degree of intracellular Ca2+ increases was correlated with the number of
preserved dopaminergic neurons. The preserved dopaminergic neurons also retained
basic functioning such as the synthesis, release, and uptake of DA.
While these experiments provided compelling evidence of the mechanism of
neuroprotection by caffeine, it must be emphasized that in this in vitro study the neurons
were exposed to much higher paraxanthine concentrations that would be expected after
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ingestion of caffeine in living animals (Burke et al., 2004). The authors note it would be
expected to see similar effects in vivo when exposed to lower concentrations (Guerreiro
et al., 2008).
Role of Intracellular Calcium in the Neuroprotective Effects of Caffeine
Calcium overview. Calcium is an important signaling molecule used in many
aspects of cell regulation. The fluctuation of Ca2+ regulates cell excitability, synaptic
plasticity, neurotransmitter release, gene regulation, and apoptosis (Fill & Copello, 2002;
Mattson, 2012; McConkey & Orrenius, 1997; R. Rizzuto et al., 2012; Usachev, Shmigol,
Pronchuk, & Verkhratsky, 1993). Ca2+ is widely recognized as the most important
signaling molecule and is highly regulated in neurons (Mattson, 2012).
Elevations of intracellular Ca2+ levels are necessary for cell signaling, however
prolonged increases in Ca2+ can result in cell death (Hongpaisan, Winters, & Andrews,
2004; Ichas & Mazat, 1998; McConkey & Orrenius, 1997; Orrenius et al., 2003; Rizzuto
et al., 2003). Ca2+ signaling requires cells to signal using brief elevations of Ca2+ levels
followed by a rapid decay, commonly known as Ca2+ oscillations (Berridge, Lipp, &
Bootman, 2000; Dupont, Abou-Lovergne, & Combettes, 2008). There are three types of
Ca2+ encoding are amplitude modification (AM), frequency modification (FM), and
amplitude and frequency modification (AFM) (De Pitta, Volman, Levine, & Ben-Jacob,
2009). With AM encoding, the strength of the stimulus is encoded by changes in
amplitude while frequency remains constant. FM encoding encodes the strength of the
stimulus in varying frequencies while the amplitude remains the same. AFM encoding is
a combination of AM and FM encoding, where the strength of the stimulus is encoded in
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a blend of changes in both frequency and amplitude. They type of encoding a cell uses
varies based on the type of cell.
Cells are suspended in a high Ca2+ concentration (in the mM range) extracellular
environment (Fill & Copello, 2002; McConkey & Orrenius, 1997). Resting free Ca2+
concentration within the cytoplasm is much lower (approximately 100 nM range) than the
extracellular environment (Berridge et al., 2000; Fill & Copello, 2002; McConkey &
Orrenius, 1997). The cytoplasm is filled with Ca2+ buffering and binding proteins to
prevent large influxes of Ca2+ inducing apoptosis (Fill & Copello, 2002; Verkhratsky,
2005).
Calcium in the Endoplasmic Reticulum. The ER is the largest intracellular
organelle present in all nerve cells and is recognized as the most prominent storage
facility for Ca2+ ions (Rizzuto et al., 2012, Verkhratsky, 2005). Neurons use changes in
Ca2+ levels as an intracellular signal in many cellular functions such as second
messengers by activating protein kinases, trigger synaptic vesicle exocytosis, and trigger
apoptosis (Brose, Petrenko, Sudhof, & Jahn, 1992; Hongpaisanet al., 2004; McConkey &
Orrenius, 1997; Orrenius et al., 2003; Rizzuto et al., 2003; Rizzuto et al., 2012). In
neurons, the ER extends throughout dendrites, axons, and soma (Verkhratsky, 2006).
Changes in local concentrations of intracellular Ca2+ are able to induce signals that
diffuse throughout the cell and elicit cellular processes at a remote location (Rizzuto et
al., 2012).
There are two main types of Ca2+ release channels on the ER: Ryanodine
receptors and Inositol trisphosphate receptors (Verkhratsky, 2006). Ryanodine receptors
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are large transmembrane proteins located on the outer face of both the smooth and rough
ER (Blaustein & Golovina, 2001; Fill & Copello, 2002). Ryanodine receptor channels are
large conductance Ca2+ channels that are able to move large numbers of Ca2+ ions (Fill &
Copello, 2002). This large efflux of Ca2+ from the ER allows for highly concentrated Ca2+
‘hotspots’ to form between the ER and mitochondria. Ryanodine receptors control Ca2+
flow in a bell-shaped dose-dependent fashion meaning activation of the receptors reliably
release Ca2+ in a bell shaped curve (Bezprozvanny, Waltras, & Ehrlich, 1991; Fill &
Copello, 2002; Verkhratsky, 2005). Ryanodine receptors are inactive when exposed to
nM and mM concentrations of ryanodine receptor agonists, but active while exposed to
μM concentrations (Bezprozvanny et al., 1991). This feature of ryanodine receptors
allows the testing of varying concentrations of paraxanthine to find the ideal
concentration for neuroprotection.
Inositol trisphosphate receptors and ryanodine receptors each have a unique way
of releasing Ca2+ as a cellular signal. Inositol trisphosphate receptors cause Ca2+ to release
in small ‘puffs’. These ‘puffs’ produce diverse amplitudes resulting from a varying
number of channels opening within a cluster (Berridge et al., 2000). This suggests
activation of inositol trisphosphate receptors affect AM encoded Ca2+ signaling.
Ryanodine receptors cause Ca2+ to release in ‘sparks’. These ‘sparks’ occur when a
cluster of ryanodine receptors open in unison causing a spontaneous spike of Ca2+ to be
released (Berridge et al., 2000, Cheng, Lederer, & Cannell, 1993). This suggests
activation of ryanodine receptors affect FM encoded Ca2+ signaling.
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Approximately 80% of ryanodine receptors are found facing the cytoplasm,
suggesting a release of Ca2+ from the ER into the cytoplasm (Verkhratsky, 2002). Free
Ca2+ ions cannot travel further than 500 nm before being bound by calreticulin, the main
Ca2+ binding protein in neurons, rendering the Ca2+ unable to make cellular changes.
(Verkhratsky, 2002). This allows for isolated Ca2+ microdomains within the cytoplasm
before becoming inactivated through a Ca2+ binding proteins.
A study showed 80% of mitochondria were found to be in contact with the ER
(Cascarano, Montisano, Pickett, & James, 1982; Copeland & Dalton, 1959). Using GFP
labeling of organelles, a study identified the mitochondria and ER were found to be
localized at less than 200 nm apart (Rizzuto et al., 1998). This localization was labelled
the mitochondria associated membrane (MAM) (Rizzuto et al., 1998). The ER and MAM
play a pivotal role in Ca2+ exchange into the mitochondria through ryanodine receptors
and inositol trisphosphate receptors. The MAM allows for Ca2+ ‘hotspots’ to form so
signaling between the ER and mitochondria occurs without interruption of Ca2+ binding
proteins. This allows for adequate functioning of mitochondrial metabolism and is a
determinant in cell life and death (Cascarano et al., 1982; Ichas & Mazat, 1998; Kluck et
al., 1997; Patergnani et al., 2011; Raturi & Simmen, 2013).
Mitochondria sense these localized ‘hotspots’ of Ca2+ and rapidly uptake the Ca2+.
The mitochondria react to the Ca2+ ‘hotspot’ as normal cellular Ca2+ signaling (Ichas &
Mazat, 1998). The fast rate of Ca2+ uptake triggers the mitochondrial PTP to open under a
low conductance state. (Ichas & Mazat, 1998). Administering caffeine and paraxanthine
will cause Ca2+ ‘hotspots’ to form within the MAM. This treatment will artificially force

21

ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE
CAFFEINE METABOLITE, PARAXANTHINE?
the PTP into stabilizing into its low conductance state preventing PTP mediated
apoptosis. Manipulating the mitochondria PTP may be a new therapeutic target to treat
PD patients in the future.
Zebrafish as a Model Organism in PD Research
General. The zebrafish, Danio rerio, have emerged as a leading model organism
for drug discovery and toxicology research. The zebrafish is small in size and easy to
house in large numbers. They provide simple detection of target phenotypes making them
essential for high-throughput screening (Zon & Peterson, 2005). Using a whole organism
allows researchers to answer biological questions that cannot be addressed in vitro (Zon
& Peterson, 2005). The zebrafish provide a high degree of genetic and physiological
similarity to mammals. The zebrafish’s forebrain dopaminergic nucleus is a homolog of
mammalian midbrain dopaminergic system (Lam, Korzh, & Strahle, 2005). As well as,
amino acid sequence conservation of proteins between mammals and the zebrafish
suggest similar protein functions (Ahmad, Noldus, Tegelenbosch, & Richardson,
2012). This is indicative of a high conservation in drug response between and humans,
estimated around 95% (Zon & Peterson, 2005).
Zebrafish embryos and larvae have transparent skin. This feature makes it
possible to detect functional and morphological changes in internal organs without killing
or dissecting the organism. Transparent skin allows the use of Ca2+ imaging with
fluorescent dye to quantify changes in Ca2+ concentration within the neurons of intact
zebrafish larvae.
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Caffeine, in non-chronic dosing, affects locomotor behaviors in a dose-dependent
fashion (Holtzman, 1989). Examining the swimming speeds in caffeine treated (10, 25,
50 mg/L) zebrafish, showed that at 25 mg/L and 50 mg/L concentration caused a
decrease in swimming speed (Ladu et al., 2015). It is important to note our experiment
will be using much lower concentrations of caffeine. However, there is no change in
swimming behaviors in concentrations less than 100 µM (Abdelkader, Chang, Kim,
Song, Kim, & Park, 2013; Capiotti et al., 2011).
Zebrafish larvae have an average baseline heart rate of approximately 130 bpm
(SD = 6.3) (Burns, Milan, Grande, Rottbauer, MacRae, & Fisherman, 2005). Caffeine
concentrations of 100 µM, exposed to zebrafish embryos, significantly increased heart
rate (Abdelkader et al., 2013). This study measured heart rate immediately after
administration and at 48, 72, and 96 hours post fertilization (hpf). The average heart rate
in the control group was 110, 110, and 112 bpm at 48, 72, and 96 hpf respectively. The
average heart rate in the 100 µM group was 122 at 72 hpf and 136 at 96 hpf. It is
important to note this study was conducted in zebrafish embryos. The planned
experiment will be using zebrafish larvae so heart rate is expected to be higher than the
embryos.
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Statement of the Problem
Evidence shows that paraxanthine exhibits neuroprotective effects in vitro
(Guerreiro et al., 2008; Xu et al., 2002; Xu et al., 2004). This study was designed as
another step toward developing information needed to evaluate the potential for clinical
applications of paraxanthine neuroprotection, by examining parathanxine effects on
neurons in an in vivo vertebrate model system. Specifically, I examined effects of
paraxanthine and caffeine in living zebrafish larvae to determine whether these drugs
have equivalent, dose-dependent effects on neuronal calcium dynamics, locomotor
activity, and heart rate. I did not directly assess neuroprotective effects of caffeine or
paraxanthine. Instead, this study was intended to obtained baseline dose-response
information on these drugs to inform future neuroprotection studies.
Hypotheses
Hypothesis 1. Bath application of paraxanthine and caffeine will increase the
amplitude of calcium oscillations from forebrain dopamine neurons in 5 dpf zebrafish in
a dose-dependent manner.
Hypothesis 1a. Amplitude of calcium oscillations during successive 20-minute
imaging blocks will significantly increase as paraxanthine concentration in the bath
solution is increased from 0 to 40 µM to 100µM to 200 µM.
Hypothesis 1b. Amplitude of calcium oscillations during successive 20-minute
imaging blocks will significantly increase as caffeine concentration in the bath solution is
increased from 0 to 50 µM to 125 µM to 250 µM.
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Hypothesis 1c. Similar amplitudes will be found for the effects of paraxanthine
and caffeine on intracellular calcium oscillations.
Rationale for Hypothesis 1. Paraxanthine is an agonist for ryanodine receptors,
ER calcium release channels. Paraxanthine is a main metabolite of caffeine, so I reasoned
that a comparable amount of either drug should both produce similar changes in calcium
oscillations. The forebrain dopamine nucleus that was imaged is a putative homolog of a
mammalian catecholamine nucleus, the locus coeruleus, that is affected in PD (Lam et
al., 2005).
Hypothesis 2. Bath application of paraxanthine and caffeine will increase
visually-evoked (light-dimming-evoked) intracellular calcium responses in forebrain
dopamine neurons in 5 dpf zebrafish in a dose-dependent manner. These hypotheses
paralleled Hypotheses 1a-1d but examined neuronal calcium increases evoked by a visual
stimulus rather than examining resting calcium levels. These hypotheses were tested in
the same group of animals by presenting the sensory stimulus twice at the end of each 20minute imaging block using to measure resting calcium.
Hypothesis 2a. The size of visually-evoked calcium responses (measured as the
percentage change in fluorescence intensity from before to immediately after the
stimulus) will significantly increase as paraxanthine concentration in the bath solution is
increased from 0 to 40 µM, to 100µM to 200 µM.
Hypothesis 2b. The size of visually-evoked calcium responses will significantly
increase as caffeine concentration in the bath solution is increased from 0 to 50 µM to
125 µM to 250 µM.
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Hypothesis 2c. A similar dose-response function (slope) will be found for the
effects of paraxanthine and caffeine on the size of visually-evoked calcium responses.
Rationale for Hypothesis 2. Paraxanthine is an agonist for ryanodine receptors,
ER calcium release channels. Paraxanthine is a main metabolite of caffeine, so the
comparable amount of should both produce similar increases in calcium. Previous studies
determined that light dimming reliably evoked action potentials within these neurons in
untreated zebrafish larvae. Calcium is increased inside neurons for up to 1s when an
action potential is fired (Grienberger & Konnerth, 2012). An increase in fluorescence
immediately following the visual stimulus was therefore considered as a stimulus-evoked
neuronal response.
Hypothesis 3. Bath application of paraxanthine and caffeine will increase resting heart
rate in 5 dpf zebrafish larvae.
Hypothesis 3a. Bath application of 200 µM Paraxanthine for 20 minutes will
increase heart rate 5 minutes later.
Hypothesis 3b. Bath application of 250 µM Caffeine for 20 minutes in 5 dpf
zebrafish larvae will increase heart rate 5 minutes later.
Hypothesis 3c. Bath application of Paraxanthine or Caffeine for 20 minutes in 5
dpf zebrafish larvae will have a similar affect heart rate.
Rationale for Hypothesis 3. Caffeine administration increases heart rate in the
zebrafish (Abdelkader et al., 2013). Paraxanthine is the main metabolite of caffeine. By
using a metabolically equivalent ratio of paraxanthine to caffeine, I reasoned that the
larvae should show the same behavioral effects. Heart rate was measured in this
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experiment as a manipulation check because if the drug application procedure worked as
expected a change in heart rate should occur.
Hypothesis 4. Bath application of paraxanthine and caffeine will decrease
spontaneous swimming activity (measured as the percentage of time spent in motion
during a 20-minute observation period) in 5 dpf zebrafish larvae in a dose-dependent
manner.
Hypothesis 4a. Swimming activity will significantly decrease as paraxanthine
concentration in the bath solution is increased from 0 to 40 µM to 100 µM to 200 µM.
Hypothesis 4b. Swimming activity will significantly decrease as caffeine
concentration in the bath solution is increased from 0 to 50 µM to 125µM to 250 µM.
Hypothesis 4c. Changes in spontaneous swimming activity will remain similar
between the caffeine and paraxanthine treated zebrafish.
Rationale for Hypothesis 4. Acute caffeine dosage decreases active voluntary
behaviors, such as spontaneous swimming behaviors, in a dose dependent manner
(Holtzman, 1989; Ladu et al., 2015). Paraxanthine is the main metabolite of caffeine. By
using a metabolically equivalent ratio of paraxanthine to caffeine I reasoned that the
larvae should show the same behavioral effects. This thesis focused on cellular
mechanisms of caffeine and paraxanthine but it is important to measure behavioral effects
of these drugs because much of PD research with zebrafish uses swimming behaviors as a
secondary measure of dopaminergic cell death, and future paraxanthine neuroprotection
studies would be expected to use both neuronal and behavioral measures of function.
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Method
Subjects
Zebrafish are housed and bred on the HSU campus in BSS 122 F. Animals care
and breeding procedures are described in detail in a facility manual (standard operating
procedures) that has been filed with the Humboldt State University IACUC for this
zebrafish facility. For the current study approximately 10 adult zebrafish from the
existing colony (approximately 5 male and 5 female) will be used as brood stock to
generate larvae for experimentation. Approximately 105 larvae, ages 4-8 days post
fertilization, will be used in experiments.
At 5 days post fertilization (dpf), larvae will be randomly assigned to one of three
conditions, consisting of 8 larvae each. Prior research on calcium response in zebrafish
neurons (n = 27) found a minimum of a 10% change in fluorescence within 24 cells when
compared to baseline measurements (Gahtan, Sankrithi, Campos, &O’Malley, 2002).
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Table 1
Experimental Design and Dosages
Caffeine
Paraxanthine
Control
N/A
N/A
Caffeine – Low
50 µM
N/A
Caffeine – Med
125 µM
N/A
Caffeine - High
250 µM
N/A
Paraxanthine – Low
N/A
40 µM
Paraxanthine – Med
N/A
100 µM
Paraxanthine – High
N/A
200 µM
Note. The study design is a 2x3 mixed factorial experiment with repeated measures.
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Table 1 shows the first factor is drug type, with two levels, caffeine and paraxanthine,
compared between subjects. The second factor is drug concentration, with three levels (a
low, intermediate, and high concentration of each drug) compared within subjects. There
are four dependent measures: the first measure, resting neuronal calcium fluorescence,
measured as the percent of pre-drug fluorescence intensity, the second measure, sensoryevoked neuronal calcium responses using a dark-flash stimulus and measured in neurons
known to be activated during dark-flash responses, the third measure, spontaneous
swimming activity, and the fourth measure, sensory-evoked swimming activity using a
dark-flash stimulus. The same animals were used to measure both spontaneous and
evoked calcium levels (measures one and two) and calcium fluorescence was measured
repeatedly in the same animals. A different group of animals were used for behavioral
measures (the same group for spontaneous and evoked swimming activity), and
measurements of swimming behavior were also made repeatedly within animals across
drug concentrations.
Multiple neurons within the target nucleus can be recorded simultaneously in a
single animal and I had originally proposed analyzing each imaged neuron as a separate
observation (I performed a statistical power analysis to determine that each group should
include at least 8 neurons measured across at least 4 animals, to achieve statistical power
of at least .80, assuming a large effect size). However, resolving individual neurons
proved to be unreliable in the recorded images, so instead each nucleus was analyzed as a
single observation. In preparations where both sides of the brain could be resolved clearly
in the same image, I recorded two nuclei per animal, but in most preparations only one
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nucleus was recorded. In total, 25 nuclei were imaged across 15 larvae and 14 of those
nuclei were included in the final statistical analysis.
Instruments and Software
Data from zebrafish behavior will be captured using two cameras. The high speed
PTEM Photon Focus camera and the time lapse Pixelink camera. These will be used to
obtain behavioral data from stimuli sent by a LabJack controlled program with
DAQFactory. The images obtained will be analyzed by a custom script to be run through
ImageJ. Images of dopaminergic cells and calcium signaling will be taken with an
Olympus Fluoview FV1000 confocal microscope using the appropriate lens.
Procedures
Calcium imaging. I proposed using one of two methods for fluorescent calcium
imaging in zebrafish neurons, either by first injecting a calcium-sensitive fluorescent dye
into neurons, or by using a transgenic zebrafish line with a genetically-encoded
fluorescent calcium indicator (GECI) protein expressed in neurons. The GECI line was
the preferred option and I was able to obtain a suitable zebrafish line, called
elavl3:GCaMP6s (doi:10.1038/nmeth.3040), from the lab of Florian Engert at Harvard
(after securing required permissions from both universities). This line expresses a GECI
in most brain neurons under the control of the elavl3 gene, which is a transcription factor
expressed in newly differentiated neurons. Therefore, no injections were done, and all
calcium imaging was performed in 5 days post fertilization (dpf) GCaMP6s larvae that
were confirmed to have inflated swim bladders (a sign of general health).
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Larvae are prepared for calcium imaging by first being embedded in low-melting
temperature agarose (ThermoFisher; 1.2% dissolved in egg water). Larvae are place with
a transfer pipette onto a clean plastic surface in a small drop of egg water and then reaspirated into a new pipette containing about 1ml of the melted agar solution (at about 28
deg C). Once suspended in the agar the larva is dripped onto a microscope cover slide,
where within 20 seconds it will be immobilized (usually in the desired dorsal-up posture)
within the hardening agar. The cover slip is then inserted into a custom imaging chamber
that allows the agar holding the larva to be in contact with a fluid solution that can be
changed rapidly and remotely, thus allowing different drug solutions to be introduced
during the imaging session without moving the larva (once in contact with the porous
agar, drug solutions diffuse through the agar, contact the larva’s skin, and are taken up
through the skin to the larva’s blood circulation. The imaging chamber is then clamped
onto the heated stage plate (maintained at 23 deg C) of the confocal microscope. An
Olympus FV1000 confocal system with a 20x .95NA water immersion objective will be
used for imaging calcium indicator fluorescence. First, a cell of interest will be identified
and documented in a saved anatomical reference image. The cells of interest include any
of the glutamatergic descending neurons in the hindbrain ( Kinkhabwala et al., 2011).
The image will be optically magnified so the cell occupies the central portion of the
imaging area. To assess baseline fluorescence the confocal will be set to automatically
acquire an image of the cell once every 10 seconds for 10 minutes (an imaging block).
The normal egg water in the imaging chamber will then be removed and replaced with
egg water containing 50 µM caffeine, and another 10 min imaging block will be run. Two
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more imaging blocks will follow, changing the caffeine solutions between each, first to
125 µM and finally to 250 µM. These concentrations of caffeine were determined from
previous research that examined zebrafish larvae responses to caffeine (Abdelkader et al.,
2013). Four imaging blocks will also be run in paraxanthine experiments, with the
solution changed between blocks as follows: 0, 40 µM, 100 µM, and 200 µM.
Administration of paraxanthine in the zebrafish have yet to be documented. Paraxanthine
concentrations were determined by using proportions based on caffeine metabolic
pathway concentrations. After imaging the larva will be de-embedded from the agar
(done with fine tools under a dissecting microscope) and returned to an individual 35mm
petri dish containing approximately 3ml of regular egg water. Approximately 24 hours
after the calcium imaging experiment larvae will be assessed for mortality so that
potential toxicity from the previous drug exposures might be detected, and following this
assessment all larvae still living will be euthanized by immersion in 0.03% tricaine
methanesulfonate for 10-20 minutes following cessation of opercular movement.
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Table 2
Timeline for Calcium Imaging Experiments
Condition
Control (pre-drug)

Data Acquired

Time for
Procedure
2min
20 min
4 min

Cumulative
Time
2 min
22 min
26 min

Heart rate imaging
Spontaneous Ca2+ imaging
Dark flash Ca2+ imaging
trials
50μM Caffeine or
Heart rate imaging
2min
28 min
2+
40μM Paraxanthine Spontaneous Ca imaging
20 min
48 min
2+
Dark flash Ca imaging
4 min
52 min
trials
125μM Caffeine or
Heart rate imaging
2min
54 min
2+
100μM Paraxanthine Spontaneous Ca imaging
20 min
74 min
2+
Dark flash Ca imaging
4 min
78 min
trials
250uM Caffeine or
Heart rate imaging
2min
80 min
2+
200uM Paraxanthine Spontaneous Ca imaging
20 min
100 min
2+
Dark flash Ca imaging
4 min
104 min
trials
Note. Each larva received all concentrations within caffeine and paraxanthine
groups. All control, caffeine, and paraxanthine solutions also contained 100μM dtubocurarine to prevent movement during imaging. Solutions were changed
manually between imaging blocks using a plastic pipette. Agar-embedded larvae
were bathed in approximately 2ml of each solution during image. N = 15 nuclei in
eight larvae for the caffeine group, and N = 11 nuclei in six larvae for the
paraxanthine group.
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Spontaneous Locomotor Behavioral Swimming Test. Larvae, at 6 dpf, will be
individually transferred, via plastic pipette, into 10mm wells containing 4 mL of egg
water positioned above a digital camera. The camera will be programmed to take images
at 1 Hz for 10 minutes each hour for a duration of six hours. The camera utilizes an
infrared light source, otherwise the experiments will be conducted in darkness to avoid
any vision mediated influences on locomotor behaviors. Post recording, larvae will be
pipetted back into a 60mm petri dish and housed in the incubator.
Behavior Analysis. At 6 dpf, larvae will be moved to singular 10 mm wells
holding 4 mL of egg water for imaging of behavioral activity. Spontaneous locomotor
time lapse recordings will be taken over the course of 6 hours for each group to be used
as a baseline. Using a custom script to quantify activity, the stacked images will be
subtracted from each other. This will leave us a new video only showing pixels that have
changed over the course of the 6 hours, thus providing us with just the fish’s swimming
behavior. A custom script will then provide an analysis of the fish’s locomotor activity in
each well providing us with percent of time the fish was in motion during the recording
period.
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Figure 10. Quantification of spontaneous calcium fluorescence. A. Raw confocal video stack
consisting of 6,000 frames. B. Projection of average pixel values across the stack. Arrow
heads show individual neuron cell bodies the tart nucleus that can be resolved. C. Threholded
image showing isolation of the target nucleus as a density (particle) of blue pixels. A smaller
particle in the upper right of the image is not included because of a size cut off. D. Isolated
region of interest for subsequently measuring each from in the stack. E. an example plot, from
the same trials as panels A-D, showing calcium fluorescence dynamics cross 20 minutes

Figure 11. Example of a visually-evoked calcium imaging trial. A-D. Confocal time lapse
projection showing average fluorescence intensity during 4 seconds at the start of the trial
scan (A), immediately before the dark flash stimulus (B), immediately after the stimulus (C),
and at the end of the scan (D). E. The corresponding fluorescence intensity plot. Colored
boxed indicate the time periods shown in A-D. Calculations of ΔF from fluorescence intensity
before and after stimulus onset is shown.Figure 12. Quantification of spontaneous calcium
fluorescence. A. Raw confocal video stack consisting of 6,000 frames. B. Projection of
average pixel values across the stack. Arrow heads show individual neuron cell bodies the tart
nucleus that can be resolved. C. Threholded image showing isolation of the target nucleus as a
density (particle) of blue pixels. A smaller particle in the upper right of the image is not
included because of a size cut off. D. Isolated region of interest for subsequently measuring
each from in the stack. E. an example plot, from the same trials as panels A-D, showing
calcium fluorescence dynamics cross 20 minutes
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Heart Rate. Larvae will be embedded in a low melting point agar on a
microscope slide. The larvae will not be anesthetized, as we will be analyzing the
treatment’s effects on heart rate. This require unimpaired functioning of the nervous
system. The larvae will be placed under a microscope to record heart rate 1 minutes. A
stage warmer is unnecessary as the larvae will spend a total time under the microscope of
approximately 5 minutes. The larvae will be removed from the agar and placed into a
60mm petri dish with standard egg water. The petri dish will be housed in an incubator
(temperature of 28.5° C; 12h/12h light/dark cycle).
Analyses
Spontaneous calcium dynamics. To draw a region of interest (ROI) around the
target nucleus for analysis, each 20 minute video, consisting of 6,000 frames (5 images
per second for 20 minutes), was first merged into a single averaged frame (averaged
value of each pixel across images). The averaged frame was then thresholded into a
binary image that isolated the nucleus as a group of pixels. That pixel group was saved as
a ROI file and then applied to each frame of the video to measure fluorescence brightness
within that region (Figure 4).
I had originally intended to analyze drug effects on fluorescence brightness as a
secondary indicator of intracellular calcium levels. However, because successive 20min
imaging blocks were separated by blocks of heart rate imaging, the viewing field had to
be moved (from the brain to the heart) and microscope settings changed, and upon
returning to the brain nucleus I could not be sure that absolute fluorescence brightness
was directly comparable to the previous imaging block. Therefore, I analyzed drug
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effects on fluorescence dynamics within imaging blocks, rather than on brightness.
Specifically, I examined the power (amplitude) of fluorescence oscillations at specific
frequencies within each 20 min imaging block. Spontaneous, low frequency (<5Hz)
calcium oscillations are common in neural circuits across species and can be altered by
drugs and neurological disease states (Kastanenka et al., 2017), therefore, it is a relevant
indicator of caffeine and paraxanthine effects on neurons in the current study. The
imaging parameters used in this study (5 Hz for 20 minutes) limited analysis to
oscillation frequencies ranging from 0.001 to 2.5 Hz. A spectral analysis of brightness
values was performed in Matlab to determine the mean power spectral
density (amplitude) in each of the following 5 frequency analysis bins (bins were
determined a priori based on constraints of the data and previous research; (Ashworth &
Bolsover, 2002; Romano, Peitri, Perrez-Schuster, Jouary, Haudrechy, & Sumbre, 2015,
Smeyne & Jackson-Lewis, 2005): 0.001 – 0.01 Hz, 0.01 – 0.05 Hz, 0.05 – 0.1 Hz, 0.1 – 1
Hz, 1-2.5 Hz.
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Figure 13. Example of a visually-evoked calcium imaging trial. A-D. Confocal time lapse
projection showing average fluorescence intensity during 4 seconds at the start of the trial scan
(A), immediately before the dark flash stimulus (B), immediately after the stimulus (C), and at
the end of the scan (D). E. The corresponding fluorescence intensity plot. Colored boxed
indicate the time periods shown in A-D. Calculations of ΔF from fluorescence intensity before
and after stimulus onset is shown.
Figure 14. Example of behavioral analysis procedures for a single 20 minute spontaneous
activity trial followed by a 1 minute startle trial (taken from a control condition recording). A.
Raw image stack of larvae in behavior recording wells. Caffeine and Paraxanthine larvae from
the same clutch were tested at the same time to avoid confounds. B. Images have been
processed by background subtraction and thresholding and circular regions of interest
manually drawn around each well (ROI numbers appear at the center of each well and the
larvae can also be seen inside most of the wells as a smaller pixel density). C. Projection of
maximum pixel intensity at each pixel across all 1260 images showing the positions occupied
by the larvae across time. The red circle indicates the well for which data are shown in D and
E. D. Distance traveled between successive video frames (1 second intervals) across 20
minutes of spontaneous activity recording followed by a 1 minute dark flash trial. The sawtooth pattern indicates the larvae swimming in typical discrete bouts separated by rest periods.
Activity during dark flash does not appear to be elevated over baseline on this trial. E. The data
acquired for each behavior recording trial.Figure 15. Example of a visually-evoked calcium
imaging trial. A-D. Confocal time lapse projection showing average fluorescence intensity
during 4 seconds at the start of the trial scan (A), immediately before the dark flash stimulus
(B), immediately after the stimulus (C), and at the end of the scan (D). E. The corresponding
fluorescence intensity plot. Colored boxed indicate the time periods shown in A-D.
Calculations of ΔF from fluorescence intensity before and after stimulus onset is shown.
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Visually-evoked calcium responses. ROIs around the target neurons were
generated as described for spontaneous fluorescence analysis. Each startle trial lasted 60
seconds with the dark flash stimulus occurring after 30 seconds. A normalized index for
stimulus induced fluorescence change (ΔF) was created by dividing the average
fluorescence during the four second preceding the stimulus from the average fluorescence
during the 4 seconds following the stimulus. This ΔF index, corresponding to the
percentage increase in fluorescence, was the dependent measure analyzed for drug and
drug concentrations effects on startle trials. Figure 5 shows and example of a visuallyevoked calcium response from the present study.
Heart rate. Heart motility was visible in the videos as a pixel contrast oscillations
within a limited region of the image. An analysis window was manually drawn around
this pixel region using ImageJ and the average brightness within the region was measured
on each frame. Brightness values were imported into Microsoft Excel and a formula was
applied that detected frames that were brighter than both adjacent frames (the adjacent
frames being those captured 200ms before and 200ms after the target frame), indicating a
repeated phase of the cardiac rhythm. The number of those repeated phases during the 1
minute recording was divided by 60 to calculate average beats per second.
Swimming behavior. For each drug and dose combination a 1,260 frame
behavior video was generated that contained 20 minutes of spontaneous swimming
(1,200 frames) followed by a dark flash startle trial (60 frames). A background
subtraction method was first applied by subtracting an image that was the averaged pixel
values across the entire video, from each video frame, creating a new video where each
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frame highlighted the pixels that identified each larva’s current position. The video was
then thresholded to set non-target pixels to zero, a procedure that is required for
automated detection of the XY coordinates of target pixels. An analysis region was drawn
around dish and the particle analysis function in ImageJ was used to record XY
coordinates for each larva on each video frame. The distance formula (distance = sqrt (x2
- x1)2 + (y2 - y1)2) was used in Excel to convert successive XY coordinate pairs into the
distance traveled by the larvae from frame to frame in units of millimeters per second
(this was straight forward as the recoding rate was 1 frame per second). From this, the
measure that was analyzed was total distance traveled across 20 minutes. For startle trials
a response index was created by dividing the distance traveled during the 60 seconds
before the startle stimulus from the distance traveled during the following 60 seconds of
darkness. Figure 6 shows steps of the analysis procedure for an example behavior video.
.
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Figure 16. Example of behavioral analysis procedures for a single 20 minute spontaneous
activity trial followed by a 1 minute startle trial (taken from a control condition recording).
A. Raw image stack of larvae in behavior recording wells. Caffeine and Paraxanthine
larvae from the same clutch were tested at the same time to avoid confounds. B. Images
have been processed by background subtraction and thresholding and circular regions of
interest manually drawn around each well (ROI numbers appear at the center of each well
and the larvae can also be seen inside most of the wells as a smaller pixel density). C.
Projection of maximum pixel intensity at each pixel across all 1260 images showing the
positions occupied by the larvae across time. The red circle indicates the well for which
data are shown in D and E. D. Distance traveled between successive video frames (1
second intervals) across 20 minutes of spontaneous activity recording followed by a 1
minute dark flash trial. The saw-tooth pattern indicates the larvae swimming in typical
discrete bouts separated by rest periods. Activity during dark flash does not appear to be
elevated over baseline on this trial. E. The data acquired for each behavior recording trial.
Figure 17. Startle swimming behaviors categorized by dose received. Control (no drug);
Low (Caff:50𝜇M/PX:40𝜇M); Med (Caff:125𝜇M/PX:100𝜇M); High
(Caff:250𝜇M/PX:200𝜇M). Error bars represent the standard error of the mean.Figure 18.
Example of behavioral analysis procedures for a single 20 minute spontaneous activity
trial followed by a 1 minute startle trial (taken from a control condition recording). A. Raw
image stack of larvae in behavior recording wells. Caffeine and Paraxanthine larvae from
the same clutch were tested at the same time to avoid confounds. B. Images have been
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Results
Spontaneous Calcium Dynamics
Hypothesis 1 stated that drug type would have similar effects on the amplitude of
calcium signaling, but the dose would increase the amplitude of the calcium oscillations.
Data were analyzed using a repeated measures ANOVA with dose (control, low,
medium, high) as the within-subjects factor and drug type (caffeine, paraxanthine) as the
between subjects factor. Mauchly’s test indicated that the assumption of sphericity for
dose has been violated, Χ2 = 11.77, p = .039, so the degrees of freedom were corrected
using Greenhouse-Geisser estimates of sphericity (ɛ = .665). Calcium oscillation
amplitude was not significantly affected by drug type, F(1, 12) = 0.161, p = .695, partial
η2 = .013, when amplitude was examined across all frequencies. Caffeine (n = 7) and
paraxanthine (n = 7) had the same effect on amplitude. Drug dose did not affect calcium
oscillation amplitude, F(1.995, 23.94) = 0.484, p = .622, partial η2 = .039, when
amplitude was examined across all frequencies. All the doses (n = 12 in each group)
administered had no effect on calcium signaling.
I performed a secondary analysis examining how drug type and dose affected
each of the frequency bins separately to better understand the effects of dose and drug
type at individual frequencies. The data were analyzed using repeated measures ANOVA
with dose (control, low, medium, high) and frequency bin (0.001 – 0.01 Hz, 0.01 – 0.05
Hz, 0.05 – 0.1 Hz, 0.1 – 1 Hz, 1-2.5 Hz) as the within-subjects factors and drug type
(caffeine, paraxanthine) as the between-subjects factor. Mauchly’s test indicated that the
assumption of sphericity for frequency has been violated, Χ2 = 204.046, p < .001, so the
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degrees of freedom were corrected using Greenhouse-Geisser estimates of sphericity (ɛ =
.319). There were no significant effects of drug dose on amplitude at any frequency bin
(bin 1, F(0.957, 11.484) = 0.173, p = .873, partial η2 = .014; bin 2, F(0.957, 11.484) =
1.311, p = .28, partial η2 = .098; bin 3, F(0.957, 11.484) = 2.056, p = .25, partial η2 =
.108; bin 4, F(0.957, 11.484) = 2.089, p = .137, partial η2 = .148; & bin 5, F(0.957,
11.484) = 0.827, p = .453, partial η2 = .065).
Drug type also had no effect on amplitude at any frequency bin (bin 1, F(1, 12) =
0.052, p = .823, partial η2 = .004; bin 2, F(1, 12) = 1.957, p = .145, partial η2 = .140; bin
3, F(1, 12) = 1.451, p = .25, partial η2 = .108; bin 4, F(1, 12) = 0.731, p = .415, partial η2
= .056; & bin 5, F(1, 12) = .381, p = .548, partial η2 = .031). Caffeine and paraxanthine
had the same effects on amplitude within each of the frequency bins.
There were no interactions between drug type and dose, (bin 1, F(3, 432) = 1.698,
p = .873, partial η2 = .014; bin 2, F(3, 432) = 1.752, p = .204, partial η2 = .127; bin 3, F(3,
432) = 1.520, p = .237, partial η2 = .112; bin 4, F(3, 432) = 0.091, p = .530, partial η2 =
.054; & bin 5, F(3, 432) = 0.733, p = .496, partial η2 = .054). Drug type affected the
amplitude within each of the frequency bins in the same way at each of the doses
administered. This is important to report as a significant interaction would suggest
caffeine and paraxanthine influence calcium signaling differently.
Evoked Calcium Response
The data were analyzed using repeated measures ANOVA with dose (control,
low, medium, high) as the within-subjects factor and drug type (caffeine, paraxanthine)
as the between-subjects factor. Mauchly’s test indicated that the assumption of sphericity
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for dose has not been violated, Χ 2 = 6.143, p = .294. Drug type did not affect the
average percent change in fluorescence (F), F(1, 12) = 1.657, p = .222, partial η2 =
.121. This supports our hypothesis and suggests that caffeine and paraxanthine affected
Ca2+ signaling in the same way. Hypothesis 2 stated that as dose increase, there would
be an increased percent change in calcium fluorescence. Dose did not affect the average
F, F(3, 36) = 0.729, p = .503, partial η2 = .057. This indicates that dose did not have an
effect on Ca2+ signaling. There was not a significant interaction between drug type and
dose on average F, F(3, 432) = 0.056, p = .982, partial η2 = .005. The interaction
between dose and drug type met the assumptions for sphericity. The interaction is
important to report since it provides information supporting there were no differences
across the average F based on the drug or dose administered.
Hypothesis 2c states that there should be a similar response index between the
drug types tested. The data were analyzed using repeated measures ANOVA with dose
(control, low, medium, high) as the within-subjects factor and drug type (caffeine,
paraxanthine) as the between-subjects factor. Mauchly’s test indicated that the
assumption of sphericity for dose has been violated, Χ 2 = 21.560, p = .001, so the
degrees of freedom were corrected using Greenhouse-Geisser estimates of sphericity (ɛ =
.459). Drug type did not significantly affect the response index of the neurons, F(1, 7) =
0.162, p = .700, partial η2 = .023. Caffeine and paraxanthine had the same effect on the
response index for Ca2+ signaling after the visually-evoked stimulus. Hypothesis 2 states
that dose should increase the response index. Dose did not have any effect on the
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response index, F(1.377, 9.639) = 0.168, p = .792, partial η2 = .023. Increasing dose did
not affect the calcium response after the visually-evoked stimulus. Dose and drug type
had no interactions effect on the response index, F(1.377, 67.473) = 0.636, p = .508,
partial η2 = .083. This supports the idea that caffeine and paraxanthine have similar
effects on Ca2+ signaling within the neuron. Hypothesis 2 states that drug type will
produce a similar slope for Ca2+ response after the dimming stimulus.
Spontaneous Locomotor Behavior
Hypothesis 4 states that drug type will not affect evoked swimming behaviors;
however, the dose will decrease spontaneous swimming behaviors. The primary analysis
investigated swimming behaviors across the 20-minute recording block. The data were
analyzed using repeated measures ANOVA with dose (control, low, medium, high) as the
within-subjects factor and drug type (caffeine, paraxanthine) as the between-subjects
factor. Mauchly’s test indicated that the assumption of sphericity for dose for total
distance has been violated, Χ2 = 11.435, p = .045, so the degrees of freedom were
corrected using Greenhouse-Geisser estimates of sphericity (ɛ = .598). Drug type did not
affect the total distance traveled across the 20 minute recording period, F(1, 10) = 0.070,
p = .797, partial η2 = .007. Administration of caffeine or paraxanthine did not change the
total distance swam. Dose did not affect the total distance traveled across the 20-minute
recording period, F(1.794, 17.942) = 1.142, p = .336, partial η2 = .103. Increasing dose
did not have an effect on the total distance swam. There was no interaction between dose
and drug type, F(1.794, 179.42) = 0685, p = .336, partial η2 = .064. Caffeine and
paraxanthine affected the total distance swam in the same way across all the doses tested.
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Mauchly’s test indicated that the assumption of sphericity for dose for average
speed has been violated, Χ2 = 12.184, p = .033, so the degrees of freedom were corrected
using Greenhouse-Geisser estimates of sphericity (ɛ = .596). Drug type did not affect the
average speed swam across the 20-minute recording period, F(1, 10) = .018, p = .897,
partial η2 = .737. Administration of caffeine and paraxanthine affected the average speed
swam in the same way. Dose did not affect the average speed swam across the 20-minute
recording period, F(1.787, 17.867) = 1.335, p = .285, partial η2 = .118. Increasing the
dose did not change the average speed the zebrafish swam. Drug type and dose did not
have an interaction, F(1.787, 178.67) = 0.881, p = 420, partial η2 = .081. Caffeine and
paraxanthine affected the average speed swam across all the doses tested.
Mauchly’s test indicated that the assumption of sphericity for dose for maximum
speed has been met, Χ2 = 10.206, p = .071, so the degrees of freedom were not corrected.
Drug type did not affect the maximum speed swam, F(1, 10) = 0.052, p = .824, partial η2
= .005. Caffeine and paraxanthine did not affect the maximum speed recorded during the
20-minute recording block. Dose did not affect the maximum speed, F(3, 30) = 2.301, p
= .097, partial η2 = .187. Increasing doses had not effect on the maximum speed recorded
during the 20-minute recording block. There was not interaction between drug type and
dose, F(3, 300) = 0.258, p = .855, partial η2 = .025. Caffeine and paraxanthine affected
the maximum speed across all the doses tested.
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A secondary analysis was performed to examine the effects of drug type and dose
on swimming behaviors on individual time bins that broke up the 20-minute recording
period into four 5-minute time bins. This allowed us to more closely examine potential
differences in metabolism rates across varying doses. The data were analyzed using
repeated measures ANOVA with dose (control, low, medium, high) and time bin (1 – 5, 6
– 10, 11 – 15, 16 – 20 minutes) as the within-subjects factors and drug type (caffeine,
paraxanthine) as the between-subjects factor. Mauchly’s test indicated that the
assumption of sphericity for dose for total distance has been violated, Χ2 = 11.540, p =
.043, so the degrees of freedom were corrected using Greenhouse-Geisser estimates of
sphericity (ɛ = .613). Mauchly’s test indicated that the assumption of sphericity for time
bin for total distance has been violated, Χ2 = 12.615, p = .028, so the degrees of freedom
were corrected using Greenhouse-Geisser estimates of sphericity (ɛ = .595). Table 3
shows drug type did not affect total distance traveled, F(1, 10) = 0.003, p = .957, partial
η2 = .000. Caffeine and paraxanthine affected the total distance swam in the same way.
Dose did not affect the total distance traveled, F(1.840, 18.401) = 1.178, p = .335, partial
η2 = .105. Table 4 shows the varying doses administered had not effects on how far the
fish swam throughout each of the time bins. Table 5 shows time bin had not effect on the
total distance swam, F(1.784, 17.844) = 0.183, p = .907, partial η2 = .018. There were no
differences in the total distance swam throughout the time bins. There was no interaction
between drug type and dose on the total distance swam, F(1.840, 184.01) = 1.126, p =
.341, partial η2 = .101. Caffeine and paraxanthine affected the total distance swam in the
same way at each of the varying doses.
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Mauchly’s test indicated that the assumption of sphericity for dose for average
speed has been violated, Χ2 = 11.611, p = .042, so the degrees of freedom were corrected
using Greenhouse-Geisser estimates of sphericity (ɛ = .612). Mauchly’s test indicated
that the assumption of sphericity for time bin for average speed has been violated, x2 =
12.273, p = .032, so the degrees of freedom were corrected using Greenhouse-Geisser
estimates of sphericity (ɛ = .597). Drug type did not affect the average swimming speed
throughout the time bins, F(1, 10) = 0.003, p = .960, partial η2 = .000. Caffeine and
paraxanthine did not have an effect on the average speed swam (Table 3). Dose did not
affect the average speed swam, F(1.837, 18.371) = 1.172, p = .328, partial η2 = .105
(Table 4). Time bin did not affect the average speed swam, F(1.792, 17.919) = 0.151, p =
.839, partial η2 = .839. Table 5 shows the average speed remained the same throughout
the time bins. There was no interaction between drug type and dose, F(1.837, 183.71) =
1.123, p = .342, partial η2 = .101. Caffeine and paraxanthine affected the average speed
swam in the same way at each of the varying doses
Mauchly’s test indicated that the assumption of sphericity for dose for maximum
speed has been violated, Χ2 = 11.741, p = .040, so the degrees of freedom were corrected
using Greenhouse-Geisser estimates of sphericity (ɛ = .580). Mauchly’s test indicated
that the assumption of sphericity for time bin for maximum speed has been met, Χ2 =
7.999, p = .159. Drug type did not affect the maximum speed swam F(1, 10) = 3.024, p =
.113, partial η2 = .232. Table 3 shows administration of caffeine or paraxanthine did not
affect swimming speed. Dose did not affect the maximum swimming speed, F(1.740,
17.404) = 1.669, p = .218, partial η2 = .143 (Table 4). Time bin had no effect on the
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maximum speed swam, F(2.101, 21.008) = 0.774, p = 480, partial η2 = .072. There were
no differences in the maximum speed swam across the time bins (Table 5). There was no
interaction between drug type and dose, F(1.740, 174.04) = 0.976, p = .417, partial η2 =
.089. Caffeine and paraxanthine produced the same results on maximum speed
throughout the varying doses.
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Table 3
Effects of drug type on behavioral trials
Caffeine
M(SD)
365.8 (135.5)
1.2 (0.6)

Spontaneous
n
95% CI
n
Total Distance (mm) 6
[-283.9, 298.2]
6
Average Speed
6
[0.5, 1.9]
6
(mm/s)
Max Speed (mm/s)
6
13.7 (2.0)
[10.7, 16.6]
6
Evoked
Total Distance (mm) 6
60.7 (33.7)
[38.9, 84.6]
6
Average Speed
6
1.0 (0.6)
[0.6, 1.4]
6
(mm/s)
Max Speed (mm/s)
6
6.1 (1.7)
[3.4, 8.9]
6
Note. *p< .05 for F test; CI = Confidence Interval around mean differences

Paraxanthine
M(SD)
358.7 (289.9)
1.2 (1.0)

95% CI
[ 298.2, -283.9]
[0.5, 1.9]

10.4 (4.1)

[7.5, 13.4]

101.6 (43.2)
1.7 (0.7)

[77.7, 125.4]
[1.3, 2.1]

8.9 (3.9)

[6.2, 11.6]

Table 4
Effect of dose on behavioral trials
Control
Low
Med
Spontaneous n M(SD) 95% CI
n M(SD) 95% CI
n M(SD)
Total
6 390.8 [192.7,
6
438.4
[199.9,
6
368.3
Distance
(294.1) 588.8]
(360.1)
676.9]
(371.4)
(mm)
Average
6
1.3
[0.6,
6
1.5
[0.7,
6
1.2
Speed
(1.0)
2.0]
(1.2)
2.3]
(1.3)
(mm/s)
Max Speed 6
11.5
[6.8,
6
13.6
[9.4,
6
13.7
(mm/s)
(7.1)
16.3]
(7.3)
17.8]
(4.4)
Evoked
Total
6 108.9
[96.6,
6
74.2
[62.0,
6
85.6
Distance
(30.9) 121.1]
(18.7)
86.3]
(56.5)
(mm)
Average
6
1.8
[1.6,
6
1.2
[1.0,
6
1.4
Speed
(0.5)
2.0]
(0.3)
1.4]
(0.9)*
(mm/s)
Max Speed 6
7.0
[5.4,
6
8.4
[5.7,
6
8.0
(mm/s)
(2.9)
8.7]
(4.1)
11.1]
(6.5)
Note: *p< .05 for F test; CI = confidence interval around mean differences

High
M(SD)
251.6
(163.8)

95% CI
[144.9,
358.2]

95% CI
[129.8,
606.8]

n
6

[0.4,
2.0]

6

0.9
(0.5)

[0.5,
1.2]

[10.8,
16.7]

6

9.3
(4.3)

[6.8,
11.8]

[53.6,
117.7]

6

55.9
(44.6)

[30.9,
80.8]

[0.9,
1.9]

6

0.9
(0.7)

[0.5,
1.3]

[3.9,
12.2]

6

6.7
(7.7)

[1.8,
11.5]
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Table 5
Effects of time bin on behavioral trials
Time
Time
Time
Bin 1
Bin 2
Bin 3
Spontaneous n M(SD) 95% CI
n M(SD) 95% CI
n M(SD) 95% CI
Total
6
350.6 [220.7,
6 363.6 [200.3,
6 360.3 [238.0,
Distance
(192.6)
480.4]
(242.2)
527.0]
(185.6)
482.6]
(mm)
Average
6
1.2
[07.3,
6
1.2
[0.7,
6
1.2
[0.8,
Speed
(0.6)
1.6]
(0.8)
1.8]
(0.6)
1.6]
(mm/s)
Max Speed
6
11.9
[9.1,
6
11.1
[8.6,
6
12.3
[9.8,
(mm/s)
(4.6)
14.7]
(4.2)
13.7]
(4.2)
14.7]
Note: *p< .05 for F test; CI = confidence interval around mean differences

Time
Bin 4
n M(SD)
6 374.5
(276.6)

95% CI
[189.6,
559.4]

6

1.2
(0.9)

[0.6,
1.9]

6

12.9
(4.1)

[10.2,
15.7]

Evoked Locomotor Behavior
The data were analyzed using repeated measures ANOVA with dose (control,
low, medium, high) as the within-subjects factor and drug type (caffeine, paraxanthine)
as the between-subjects factor. Mauchly’s test indicated that the assumption of sphericity
for dose has been met for total distance, Χ2 = 7.033, p = .221; for average speed, Χ2 =
7.033, p = .221; and for maximum speed, Χ2 = 6.725, p = .244.
In contrast to spontaneous swimming, Table 3 shows drug treatments did
influence evoked swimming in the light dimming startle assay. There was a main effect
of drug type on swimming distance in the 20 seconds following light dimming, F(1, 10) =
7.286, p = .022, partial η2 = .422, 95% CI of the mean differences[74.581, 7.131], with
the Bonferroni pairwise comparison showing caffeine treated larvae swam significantly
less than paraxanthine treated larvae (M = 60.711, SD = 33.710 and M = 101.567 SD =
43.150 mm distance for caffeine and paraxanthine groups, respectively). Drug type also
affected average swimming speed during startle, F(1, 10) = 7.286, p = .022, partial η2 =
.422, 95% CI of the mean differences [1.213, 0.119], with the Bonferroni pairwise
comparison test showing caffeine treated larvae swimming significantly slower than
paraxanthine treated larvae (M = 1.012 SD = 0.562 and M = 1.693, SD = 0.719 mm/s
respectively) The maximum speed reached was not affected by drug type, F(1, 10) =
2.499, p = .145, partial η2 = .200.
There was a main effect of drug dose for total distance swam during startle
swimming, F(3, 30) = 9.049, p < .001, partial η2 = .475. The Bonferroni pairwise

ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE
CAFFEINE METABOLITE, PARAXANTHINE?
comparisons of dose was significant showing the control group (M = 108.9, SD = 30.9)
swam further than the low dose group (M = 74.2, SD = 18.7) with a 95% CI[16.846,
52.550] and the high dose group (M = 55.9, SD = 44.6) with a 95% CI[22.253, 83.788].
Table 5 shows the average distance swam for each of the doses and the corresponding
confidence intervals. There was no significant interaction between the drug dose
administered and time bin for maximum speed, F(3.945, 39.447) = 3.044, p = .233,
partial η2 = .233. Figure 8 shows the maximum speed across the different doses and time
bin.
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Figure 19. Startle swimming behaviors categorized by dose received.
Control (no drug); Low (Caff:50𝜇M/PX:40𝜇M); Med
(Caff:125𝜇M/PX:100𝜇M); High (Caff:250𝜇M/PX:200𝜇M). Error bars
represent the standard error of the mean.

Figure 20. Maximum swimming speed (mm/s) categorized by dose
received. Control (no drug); Low (Caff:50𝜇M/PX:40𝜇M); Med
(Caff:125𝜇M/PX:100𝜇M); High (Caff:250𝜇M/PX:200𝜇M)Figure 21.
Startle swimming behaviors categorized by dose received. Control (no
drug); Low (Caff:50𝜇M/PX:40𝜇M); Med (Caff:125𝜇M/PX:100𝜇M); High
(Caff:250𝜇M/PX:200𝜇M). Error bars represent the standard error of the
mean.
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Figure24.
22.Shows
Maximum
swimming
(mm/s)
by dose
Figure
the average
heartspeed
rate in
beats categorized
per second (bps)
sorted by dose
received. Control (no drug); Low (Caff:50𝜇M/PX:40𝜇M); Med
(Caff:125𝜇M/PX:100𝜇M); High (Caff:250𝜇M/PX:200𝜇M)
Figure 23. Maximum swimming speed (mm/s) categorized by dose
received. Control (no drug); Low (Caff:50𝜇M/PX:40𝜇M); Med
(Caff:125𝜇M/PX:100𝜇M); High (Caff:250𝜇M/PX:200𝜇M)
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Heart Rate Analysis
Hypothesis 3 suggests that heart rate will be increased by both drug type and
dose. The data were analyzed using repeated measures ANOVA with dose (control, low,
medium, high) as the within-subjects factor and drug type (caffeine, paraxanthine) as the
between-subjects factor. Mauchly’s test indicated that the assumption of sphericity for
dose has been met, Χ2 = 4.654, p = .462. Drug type had no effect on heart rate, F(1, 11) =
0.838, p = .380, partial η2 = .071. Caffeine (n = 7) and paraxanthine (n = 6) had the same
effects on heart rate. Figure 9 shows dose had a significant effect on heart rate (bps), F(3,
33) = 11.187, p < .001, partial η2 = .504. The Bonferroni pairwise comparisons of heart
rate was significant showing the control group (M = 1.75, SD = 0.442 bps) was
significantly higher than the low dose group (M = 1.36, SD = 0.230 bps) with a 95%
CI[0.101, 0.674] and the medium dose group (M = 1.76, SD = 0.270 bps) with a 95%
CI[0.192, 0.956]. Figure 9 shows the control group had the highest heart rate, M = 1.750,
SD = 0.442, the low dose group had the second highest heart rate, M = 1.364, SD = 0.230,
followed by the highest dose group, M = 1.349, SD = 0.298, and the medium dose group
had the lowest heart rate, M = 1.176, SD = 0.270. There was no interaction between drug
type and dose received on heart rate, F(3, 363) = 0.060, p = .980, partial η2 = .005.
Caffeine and paraxanthine produced the same results across all doses tested.
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Figure 25. Shows the average heart rate in beats per second (bps) sorted
by dose received.
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Discussion
These experiments were intended to provide information about effects of caffeine
and paraxanthine on intracellular Ca2+ and behavior in an important animal model
system, zebrafish larvae. The lack of consistent or hypothesized caffeine and
paraxanthine effects suggest that the dose range I used may have been too low to produce
the intended effects in vivo within zebrafish larvae. Prior experiments investigating the
effects of caffeine and paraxanthine used much larger doses, for example, Ladu et al.
(2015) exposed larval zebrafish to 0.257 mM caffeine, whereas the highest concentration
used in the current study was 250μM. Guerreiro et al., (2008) tested the neuroprotective
qualities exposed cell cultures to 25 mM. However, it had been suggested lower doses
would be able to achieve the same effects while testing the effects of these drugs in vivo
on intracellular calcium concentrations (Guerreiro et al., 2008). The doses used were
estimates based on prior caffeine research in zebrafish models in which the zebrafish
were expected to survive several days past drug administration (Abdelkader et al., 2013).
Prior research suggests exposure to caffeine or paraxanthine results in an increase
of intracellular calcium concentrations via activation of ryanodine receptors (Guerreiro et
al., 2008). Per hypothesis 1, I expected to see a main effect across the doses, as an
increase in dose should result in changes in Ca2+ signaling. Contradictory to my
hypothesis and what the literature suggested, dose did not affect the amplitude of the
calcium oscillations. The concentrations were estimated based on prior research
demonstrating the effects of caffeine administration in which the zebrafish also survived
72 hours post-administration (Abdelkader et al., 2013). The last point is important
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because I chose a dose range that would be applicable in neuroprotection studies, so I
wanted to avoid toxic concentrations. Ryanodine receptors release Ca2+ in a bell-shaped
dose-dependent fashion, with the receptors only activating the Ca2+ release channels in
the intermediate range (Bezprozvanny et al., 1991; Fill & Copello, 2002; Verkhratsky,
2006). It was expected that the dose administered would influence the frequency or
amplitude of Ca2+ oscillations (Berridge et al., 2000, Cheng et al., 1993). However, the
dose of caffeine or paraxanthine showed no effect on the frequency or amplitude of Ca2+
oscillations. It is possible the concentration of caffeine or paraxathine was either too low
or too high to activate the Ca2+ release channels resulting in changes in intracellular Ca2+
concentration or affect Ca2+ oscillations.
The literature suggests ryanodine receptors affect Ca2+ signaling by affecting the
FM encoding of the Ca2+ signal. I broke down the ranges of frequencies measured into
five bins (0.001 – 0.01 Hz, 0.01 – 0.05 Hz, 0.05 – 0.1 Hz, 0.1 – 1 Hz, 1-2.5 Hz) to assess
drug effects on Ca2+ oscillations resulting at each individual frequency bin. I did not
expect to see a main effect of drug type within the frequency bins. The results are
congruent with the expectation there would be no main effect for drug type, per
hypothesis 1 This is supportive to the claim that caffeine and paraxanthine have similar
effects on Ca2+ signaling, specifically the amplitude of the frequencies. It was anticipated
the changes in dose would impact Ca2+ oscillations, per hypothesis 1. The results did not
coincide with the literature suggesting administration of caffeine or paraxanthine would
result in increases of intracellular Ca2+ concentrations through activation of ryanodine
receptors (Guerreiro et al., 2008).
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There were several limitations affecting the analysis of spontaneous Ca2+
dynamics. Firstly, I created the ROIs surrounding the entire neuron cluster, rather than
around the individual neurons forming the cluster. If the individual cells creating the
cluster were oscillating at different times, the ROIs I used would not have been able to
detect the changes. Using several smaller ROIs within each cluster may have allowed the
detection of changes in the oscillations. Second, the imaging speed used (5 Hz) could
have also prevented detection of any frequencies above 2.5 Hz. The GCaMP transgenic
line has been recorded to respond up to at least 20 Hz (Kim & Ziff, 2014). There may
have been effects on higher frequencies; however, the parameters used to record the
neurons would not have been able to capture these effects, thus restricting the analysis to
frequencies 2.5 Hz and below.
Previous research has not explored changes in intracellular calcium
concentrations linked to caffeine administration within the zebrafish. Paraxanthine
administration to the zebrafish has not been documented within the literature. However,
previous studies of intracellular calcium release channels suggest administration of
caffeine or paraxanthine should produce an increase in intracellular calcium levels after a
stimulus (Grienberger et al., 2012; Fill & Copello, 2013). Since ryanodine receptors
release Ca2+ in a dose-dependent bell-shaped curve, it’s possible the doses used could
have been either too low or too high. My results are not congruent with current literature,
as the trails receiving different doses were similar to the control group. This suggests the
doses administered may not have been within the correct range to produce the intended
effects. There were no difference between caffeine and paraxanthine administration. This
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coincides with the hypothesized outcome, however, since neither drug showed significant
effects relative to the pre-drug control condition, it is impossible to interpret the lack of a
main effect of drug type as evidence that the two drugs have equivalent physiological
actions.
Prior research suggests caffeine exposure increases the heart rate in zebrafish
(Abdelkader et al., 2013). The 200μM dose of caffeine did significantly affect the heart
rate of the zebrafish. The current literature states the average resting heart rate in a
zebrafish embryo is 2.16 bps (Burns et al., 2005). The control group, averaging at 1.75
bps, has a lower average resting heart rate than what the literature suggest. The literature
states embryos exposed to doses of caffeine above 100 µM significantly increases heart
rate over control groups (Abdelkader et al, 2013). My results do not coincide with current
literature, as the control condition in the current study had the highest heart rate, an
opposite of caffeine from what has been previously reported . One possibility that could
explain this is that heart rate was measured 4 times across 104 minutes in the current
study, and the duration of restraint and exposure to the imaging laser may have led to a
lower heart rate as part of general fatigue response to the experiment. However, none of
the larvae died during calcium imaging and all were successfully de-embedded
afterwards.
The differences in spontaneous swimming behaviors attributed to change in dose
of the zebrafish post treatment were not consistent with previous reports (Holtzman,
1989; Ladu et al., 2015). Acute caffeine exposure was shown to decrease active voluntary
behaviors, including spontaneous swimming behaviors, in a dose dependent fashion, in
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two separate studies (Holtzman, 1989; Ladu et al., 2015). However, I saw no significant
differences between the total distance traveled, average speed, or the minimum speed
during the 20 minute time bin across the four doses tested in this experiment. Doses of
caffeine under 100 µM do not produce changes in swimming behaviors (Abdelkader et
al., 2013; Capiotti et al., 2011). Since paraxanthine is the main metabolite of caffeine, I
assumed that there would be no changes in swimming behavior after exposure to 80 µM
of paraxanthine. As the low dose conditions for caffeine and paraxanthine was less than
the aforementioned concentrations, my results for the low dose condition are congruent
with previous research as the low dose group was not significantly different from the
control group.
I broke up the 20 minute time bin into four sets of 5 minute time bins to more
closely examine the effects possibility that drug effects change over time within each 20
minute behavior recording. There were no significant differences in voluntary swimming
behaviors across the time bins. However, there was a significant interaction between the
dose and time bin. This interaction suggests the varying doses may influence the speed
the zebrafish metabolizes caffeine and paraxanthine.
By using a metabolically equivalent ratio of paraxanthine to caffeine, I did not
expect to see any main effects of drug type in the analysis. My results were consistent
with our hypothesis as there were no discernible differences between the groups treated
with caffeine or paraxanthine. To some extent these results support the suggestion that
caffeine and paraxanthine affect the same receptors to produce similar behaviors.
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However, as mentioned previously, the lack of significant different across drug dosages
limits any interpretations of these results.
One clear limiation to my experimental design was that time and drug dosage
were confounded, since drugs were given as progressively higher concentrations over
time and measurements were made repeatedly. I was unable to counterbalance the doses
administered during this experiment. It would have been difficult to ensure that the higher
doses would have been fully flushed from the zebrafish’s system before testing the lower
doses. This makes it possible that other processes related to the passage of time or
experimental procedures, including simple fatigue, may have influenced cellular or
behavioral responses to the drugs. It is also possible that prolonged exposure to affected
results, for example, if previous exposure to lower doses bunted the responses to higher
doses through a type of tolerance or habituation mechanism.
Future research is needed to provide further understanding of the effects caffeine
and paraxanthine on Ca2+ signaling. The next step would be to test a wider range of
doses, which will provide information on the ideal dose to activate ryanodine receptors in
order to affect intracellular Ca2+ concentrations. Increasing the imaging speed would
allow researchers to analyze a broader range of frequencies to identify changes in Ca2+
oscillations this experiment was unable to assess due to the parameters of the Ca2+
imaging. To avoid confounds related to time and previous drug exposure, any follow up
experiment should probably use a between subjects design in which animals receive only
one exposure to the drug.

65

ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE
CAFFEINE METABOLITE, PARAXANTHINE?
The neuroprotective effects of caffeine are supported by a numerous studies
investigating the effects in humans, animal models, and in cell. Calcium, the most
prominent signaling molecule within cells, is known to have a role in inducing apoptosis.
Several studies have linked PD-related DA death to complications with calcium. The
neuroprotective qualities of caffeine are attributed to its main metabolite paraxanthine
which causes the release of calcium from the ER via ryanodine receptors. Although this
study did not provide evidence caffeine’s or paraxanthine’s effect on intracellular
calcium signaling, the literature still supports caffeine as a strong candidate for a potential
therapeutic treatment in neurodegenerative diseases.
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Appendix A: Confocal Trigger for Dark Flash Calcium Imaging
light = 1
confocal = 0
while (1)
if (confocal == 1)
light = 0
delay (var.delay)
light = 1
endif
endwhile
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Appendix B: Spontaneous and Dimming Startle Script
while (1)
while (var.capture == 1)
//pixelink1 = 5
pixelink1 = 5
delay (.2)
//pixelink1 = 0
Pixelink1 = 0
var.pics = var.pics +1
delay (.79) // .5Hz frame rate
endwhile
endwhile
//equal recording time before and after stim
var.capture = 0
var.taps = 0
var.trials = 0
delay (120)
while (var.numdims > var.dims)
//DIM
var.trials = var.trials +1
toplight = 1
var.capture = 1
delay (car.prestim*60)
lightled = 1
highspeed = 1
toplight = 0
delay (var.lightoff*60)
var.capture = 0
highspeed = 0
lightled = 0
var.dims = var.dims +1 //count up another trial
end while
endseq(cameras)
toplight = 1
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Appendix C: Spectral Analysis Script for Analyzing Calcium Oscillations
Treatment ={‘PX’};%%These first two lines are for uploading
data from folders, probably not necessary
date={'6-21'};%%
close all
bin1 = [ .001 .01 .05 .1 1];%%setting the lower bounds for
the bins
bin2 = [ .01 .05 .1 1 2.5];%%setting the upper bounds for
the bins
color=('bgrk');%%colors for graphing different data sets
Exp_cond = ([Control, low_dose, med_dose,
high_dose]);%%list of data sets to be analyzed
for j=1%:4
x = Exp_cond(:,j);
dt=.2;
T=1200;

xf = fft(x);
Sxx = 2*dt^2/T * xf.*conj(xf); %2. Compute the power
spectrum.
Sxx = Sxx(1:length(x)/2+1); %3. Ignore negative
frequencies.
df = 1/max(T); %4. Determine the frequency resolution.
fNQ = 1/dt/2; %5. Calculate the Nyquist Frequency
faxis = (0:df:fNQ); %6. Construct the frequency axis.

C=sort(abs(Sxx),'descend'); % Finding dominant frequencies
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norm=C(2); % Choosing largest frequency to normalize data

for i=1:length(bin1)
J=intersect(find(faxis>=bin1(i)),find(faxis<=bin2(i)))
;%Determining indices in faxis corresponding to
frequencies in bin i
a=min(J);% index (in faxis) of lowest frequency in bin
i
b=max(J);%index (in faxis) of highest frequency in bin
i
A(a:b)=Sxx(a:b);%determining power of frequencies in
bin i

B = (Sxx(a:b)/norm); %normalizing bin i
mean1(j,i+1)=real(mean(B));%calculating mean of bin i
std1(j,i+1)=real(std(B));%calculating std of bin i
clear A
clear B
clear J

end

% end for i

end % end for j

%%graph
errorbar(mean1(1,:),std1(1,:),color(1),'LineStyle','none')
hold on
plot((2:1:length(bin1)+1), mean1(1,2:6),[color(1)
'*'],'MarkerFaceColor',color(1))
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errorbar(mean1(2,:),std1(2,:),color(2),'LineStyle','none')
plot((2:1:length(bin1)+1), mean1(2,2:6),[color(2)
'*'],'MarkerFaceColor',color(2))
errorbar(mean1(3,:),std1(3,:),color(3),'LineStyle','none')
plot((2:1:length(bin1)+1), mean1(3,2:6),[color(3)
'*'],'MarkerFaceColor',color(3))
errorbar(mean1(4,:),std1(4,:),color(4),'LineStyle','none')
plot((2:1:length(bin1)+1), mean1(4,2:6),[color(4)
'*'],'MarkerFaceColor',color(4))
xtick=[1 2 3 4 5 6 7 8];
myxticklabel={'','(0.001-0.01)','(0.01-0.05)','(0.050.1)','(.1-1)','(1-2.5)','', ''}
set(gca,'XTick',xtick,'XTickLabels',myxticklabel,'Fontsize'
,12)
xlabel('Frequency ranges (Hz)','FontSize',14)
ylabel('Normalized power', 'FontSize',14)
legend('','Control','','40um','','100um','','200um')
title(['Normalized power of different frequencies, '
date{1} ' (' treatment{1} ')'],'FontSize',14)
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